Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding

NCT02843633 is registered in ClinicalTrials.gov with Biosensors Europe SA as lead sponsor.

NCT NCT02843633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02843633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of the BioFreedom™ Biolimus A9™ Drug Coated Stent in Patients at High Risk for Bleeding
Lead sponsor
Biosensors Europe SA
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 14, 2017
Completion date
March 31, 2021
Enrollment
1,203 (actual)
Sites
66

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, high bleeding risk